20(s)-Ginsenoside Rg3 Promotes Senescence and Apoptosis in Gallbladder Cancer Cells via the P53 Pathway [Corrigendum]

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s230835
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

20(s)-Ginsenoside Rg3-Loaded Magnetic Human Serum Albumin Nanospheres Applied to HeLa Cervical Cancer Cells in Vitro

Bio-Medical Materials and Engineering
MedicineBiomaterialsBiomedical Engineering
2014English

20(s)-Ginsenoside Rg3 Protects Kidney From Diabetic Kidney Disease via Renal Inflammation Depression in Diabetic Rats

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2020English

McL1 Gene Silencing Promotes Senescence and Apoptosis of Glioma Cells via Inhibition of the PI3K/Akt Signaling Pathway

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

Shikonin Induces Apoptosis and G0/G1�phase Arrest of Gallbladder Cancer Cells via the JNK Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2017English

EFFECTS OF GINSENOSIDE Rg3 ON THE PROLIFERATION OF GLIOMA CELLS AND NF-κB SIGNALLING PATHWAY

Farmacia
ToxicologyPharmaceuticsPharmacology
2019English

An Amphiphilic Peptide Induces Apoptosis Through the miR29b-p53 Pathway in Cancer Cells

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2016English

Kaempferol Induces Apoptosis in Ovarian Cancer Cells Through Activating P53 in the Intrinsic Pathway

Food Chemistry
MedicineAnalytical ChemistryFood Science
2011English

GKN2 Promotes Oxidative Stress-Induced Gastric Cancer Cell Apoptosis via the Hsc70 Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Ginsenoside Rb1 Inhibits Proliferation and Promotes Apoptosis by Regulating HMGB1 in Uterine Fibroid Cells

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy